| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Adaptive Biotechnologies Corporation (ADPT) have been net sellers, shedding 1,417,892 shares worth roughly $30.5M on balance. In the past 30 days, 0 insiders bought and 3 sold. Sales set the recent tone.
Not all activity pointed one way: 3 insiders sold in the same window. Classified under Biotechnology (Health Care sector), ADPT's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.18M | $54.36M | - | |
| Other | 401.3K | $10.00M | -5,000 | |
| CFO | 256.7K | $6.40M | - | |
| Other | 230.7K | $5.75M | -105,762 | |
| Other | 113.5K | $2.83M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 16, 2021 | Griffin Michelle Renee80 | Director | Sale+OE | 6,000 | $65.08 | $390,480.00 | -80.0% | -46.4% | -75.9% | |
| Feb 16, 2021 | Hershberg Robert64 | Director | Sale+OE | 2,000 | $65.45 | $130,900.00 | -57.1% | -46.4% | -75.9% | |
| Feb 16, 2021 | Rubinstein Julie78 | President | Sale+OE | 30,000 | $65.61 | $1,968,431.98 | -45.1% | -46.4% | -75.9% | |
| Feb 11, 2021 | Rubinstein Julie78 | President | Sale+OE | 30,000 | $63.12 | $1,893,554.35 | -63.1% | -48.9% | -76.1% | |
| Feb 10, 2021 | Robins Chad M62 | CEO And Chairman | Sell | 30,000 | $62.31 | $1,869,322.41 | -0.2% | -47.2% | -73.5% | |
| Feb 9, 2021 | Rubinstein Julie78 | President | Sale+OE | 30,000 | $62.25 | $1,867,532.37 | -71.9% | -48.2% | -72.2% | |
| Feb 5, 2021 | Rubinstein Julie78 | President | Sale+OE | 15,000 | $59.96 | $899,328.00 | -60.4% | -40.4% | -72.8% | |
| Feb 4, 2021 | Rubinstein Julie78 | President | Sale+OE | 30,000 | $59.37 | $1,781,099.85 | -68.3% | -42.2% | -72.8% | |
| Feb 3, 2021 | Robins Harlan S83 | Chief Scientific Officer | Sale+OE | 7,790 | $59.58 | $464,158.10 | -77.8% | -40.9% | -74.1% | |
| Feb 2, 2021 | Rubinstein Julie78 | President | Sale+OE | 30,000 | $57.26 | $1,717,843.45 | -69.2% | - | - |